TH17RORTH17

Laura A Solt1, Naresh Kumar, Philippe Nuhant

  • 1Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA.

Nature
|April 19, 2011
PubMed
概括

一种新的化合物SR1001专门针对RORα和RORγt核受体. 这种抑制有效地抑制了T(H) 17细胞的分化和功能,为自身免疫性疾病的治疗提供了潜力.